- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02650765
S100 Biomarker in the Acute Management of Mild Head Injuries (S100)
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
A prospective clinical head injury study conducted at the Emergency Department of the Tampere University Hospital, which is situated in Tampere, Finland. The hospital takes care of an catchment area of 524 447 inhabitants both from urban and rural areas. About 100 000 patients are treated in the Emergency department annually.
The study aims to improve the emergency evaluation of patients with an acute head injury, especially a mild head injury. About 80% of head CT scan performed on head injury patients in the Emergency Department of the Tampere University Hospital are negative (= no acute traumatic lesion). There is an urgent need to update the head CT imaging criteria/indications in the context of acute head injury in order to reduce the number of unnecessary scanning. More selective head CT indications result in considerable health care savings and decreased exposure to ionizing radiation, among other benefits.
In this study, the investigators implement the "Scandinavian guidelines for initial management of minimal, mild and moderate head injuries in adults" criteria as part of the emergency care of adults head injury patients. By enrolling a large consecutive sample of patients the investigators are validating this new guideline. Emergency department assessment data is combined with long-term outcome parameters and blood-based biomarkers of neurotrauma.
The main aims of the study are:
- the validation of the Scandinavian guidelines for initial management of minimal, mild and moderate head injuries in adults
- the examination of novel blood-based biomarkers of acute brain injury that correlate with the radiological severity of the injury and the long-term outcome
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
-
Tampere, Finland, 33521
- Tampere university Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Head injury
Exclusion Criteria:
- Age under 18 years
Study Plan
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Non-contrast head CT
Time Frame: 0-72h
|
Head CT findings: Intracranial traumatic lesions
|
0-72h
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Glasgow Outcome Scale Extended
Time Frame: 1 week, 6 months, 1 year, and 2 years
|
Glasgow Outcome Scale Extended
|
1 week, 6 months, 1 year, and 2 years
|
Modified Rankin Scale
Time Frame: 1 week, 6 months, 1 year, and 2 years
|
Modified Rankin Scale
|
1 week, 6 months, 1 year, and 2 years
|
Rivermead PCS Questionnaire
Time Frame: 1 week, 6 months, 1 year, and 2 years
|
Rivermead PCS Questionnaire
|
1 week, 6 months, 1 year, and 2 years
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Teemu M Luoto, MD, PhD, Tampere university Hospital
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- R15045
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Brain Injury
-
Brent MaselThe Moody FoundationCompletedChronic Traumatic Brain InjuryUnited States
-
Toronto Rehabilitation InstituteCentre for Aging and Brain Health Innovation; Ontario Neurotrauma FoundationUnknownBrain Injuries, Traumatic | Brain Injury, Chronic | Brain Injury Traumatic Severe | Brain Injury Traumatic ModerateCanada
-
BrainScope Company, Inc.RecruitingTBI (Traumatic Brain Injury) | Concussion, Brain | MTBI - Mild Traumatic Brain Injury | Closed Head InjuryUnited States
-
University of TurkuTurku University Hospital; The Finnish Funding Agency for Technology and Innovation... and other collaboratorsCompletedBrain Injuries | TBI (Traumatic Brain Injury) | Brain Injuries, Traumatic | Traumatic Brain Injury | Injury, Brain, TraumaticFinland
-
University of Sao Paulo General HospitalUnknownTraumatic Brain Injury | Severe Brain Injury | Closed Traumatic Brain InjuryBrazil
-
Center for Vision Development, New Market, MarylandUnknownBrain Injuries | Brain Injuries, Traumatic | Traumatic Brain Injury | Brain Injury, Chronic | Injury, Brain, TraumaticUnited States
-
Queen Mary University of LondonCompleted
-
Fondazione per la Ricerca Ospedale MaggioreCompletedBrain Injuries, Traumatic | Brain Injury Traumatic Severe | Brain Injury Traumatic ModerateItaly
-
Assiut UniversityUnknown
-
Institut National de la Santé Et de la Recherche...Institut National de Recherche en Informatique et en AutomatiqueNot yet recruitingTBI (Traumatic Brain Injury)France
Clinical Trials on Indications for head CT imaging after acute head injury
-
Banyan Biomarkers, IncUnited States Department of DefenseCompletedTraumatic Brain InjuryUnited States, Hungary, Germany
-
BioDirection IncNot yet recruitingBrain Injuries, Traumatic
-
University of MiamiCompletedHead and Neck Cancer | Head and Neck Squamous Cell CarcinomaUnited States
-
Bartın UnıversityRecruiting
-
Tactile MedicalCompletedHead and Neck Cancer | Head and Neck Neoplasms | Head and Neck LymphedemaUnited States
-
National Cancer Institute (NCI)NRG OncologyRecruitingStage III Lung Cancer AJCC v8 | Stage II Lung Cancer AJCC v8 | Unresectable Lung Non-Small Cell Carcinoma | Locally Advanced Lung Non-Small Cell Carcinoma | Locally Recurrent Lung Non-Small Cell CarcinomaUnited States
-
City of Hope Medical CenterNational Cancer Institute (NCI)SuspendedGlioblastoma | Malignant GliomaUnited States